Lably
Skip to content

Azficel-T

Medication for nasolabial fold wrinkles

  • 1 min read
  • 1 chapters

Explore on Lably

ToursExplore Lably’s 3D tours

The treatment is autologous, meaning it uses the patient’s own cells. Specifically, fibroblasts—cells involved in skin structure and repair—are extracted from a small skin sample, cultured in a laboratory to increase their number, and then re-injected into the patient’s skin to improve appearance.

Azficel-T was approved for medical use in the United States in June 2011.

More in Health

Food and Drug AdministrationFederal agency of the United States Department of Health and Human ServicesCenters for Disease Control and PreventionUnited States government public health agencyNauseaMedical symptom or conditionSeizurePeriod of symptoms due to excessive or synchronous neuronal brain activityVomitingExpulsion of stomach contents via the mouth or noseIntravenous therapyMedication administered into a vein